TY - JOUR
T1 - Cardiovascular Testing in the United States during the COVID-19 Pandemic
T2 - Volume Recovery and Worldwide Comparison
AU - Hirschfeld, Cole B.
AU - Dorbala, Sharmila
AU - Shaw, Leslee J.
AU - Villines, Todd C.
AU - Choi, Andrew D.
AU - Better, Nathan
AU - Cerci, Rodrigo J.
AU - Karthikeyan, Ganesan
AU - Vitola, João V.
AU - Williams, Michelle C.
AU - Al-Mallah, Mouaz
AU - Berman, Daniel S.
AU - Bernheim, Adam
AU - Biederman, Robert W.
AU - Bravo, Paco E.
AU - Budoff, Matthew J.
AU - Bullock-Palmer, Renee P.
AU - Chen, Marcus Y.
AU - Dilorenzo, Michael P.
AU - Doukky, Rami
AU - Ferencik, Maros
AU - Geske, Jeffrey B.
AU - Hage, Fadi G.
AU - Hendel, Robert C.
AU - Koweek, Lynne
AU - Murthy, Venkatesh L.
AU - Narula, Jagat
AU - Rodriguez Lozano, Patricia F.
AU - Shah, Nishant R.
AU - Shah, Amee
AU - Soman, Prem
AU - Thompson, Randall C.
AU - Wolinsky, David
AU - Cohen, Yosef A.
AU - Malkovskiy, Eli
AU - Randazzo, Michael J.
AU - Lopez-Mattei, Juan
AU - Parwani, Purvi
AU - Shetty, Mrinali
AU - Pascual, Thomas N.B.
AU - Pynda, Yaroslav
AU - Dondi, Maurizio
AU - Paez, Diana
AU - Einstein, Andrew J.
AU - INCAPS COVID 2 Investigators Group
AU - Morrissey, Brian
N1 - Funding Information:
Study supported by the International Atomic Energy Agency. M.C.W. supported by the British Heart Foundation (grant no. FS/ICRF/20/26002)
PY - 2023/10
Y1 - 2023/10
N2 - Purpose: To characterize the recovery of diagnostic cardiovascular procedure volumes in U.S. and non-U.S. facilities in the year following the initial COVID-19 outbreak. Materials and Methods: The International Atomic Energy Agency (IAEA) coordinated a worldwide study called the IAEA Noninvasive Cardiology Protocols Study of COVID-19 2 (INCAPS COVID 2), collecting data from 669 facilities in 107 countries, including 93 facilities in 34 U.S. states, to determine the impact of the pandemic on diagnostic cardiovascular procedure volumes. Participants reported volumes for each diagnostic imaging modality used at their facility for March 2019 (baseline), April 2020, and April 2021. This secondary analysis of INCAPS COVID 2 evaluated differences in changes in procedure volume between U.S. and non-U.S. facilities and among U.S. regions. Factors associated with return to prepandemic volumes in the United States were also analyzed in a multivariable regression analysis. Results: Reduction in procedure volumes in April 2020 compared with baseline was similar for U.S. and non-U.S. facilities (−66% vs −71%, P =.27). U.S. facilities reported greater return to baseline in April 2021 than did all non-U.S. facilities (4% vs −6%, P =.008), but there was no evidence of a difference when comparing U.S. facilities with non-U.S. high-income country (NUHIC) facilities (4% vs 0%, P =.18). U.S. regional differences in return to baseline were observed between the Midwest (11%), Northeast (9%), South (1%), and West (−7%, P =.03), but no studied factors were significant predictors of 2021 change from prepandemic baseline. Conclusion: The reductions in cardiac testing during the early pandemic have recovered within a year to prepandemic baselines in the United States and NUHICs, while procedure volumes remain depressed in lower-income countries.
AB - Purpose: To characterize the recovery of diagnostic cardiovascular procedure volumes in U.S. and non-U.S. facilities in the year following the initial COVID-19 outbreak. Materials and Methods: The International Atomic Energy Agency (IAEA) coordinated a worldwide study called the IAEA Noninvasive Cardiology Protocols Study of COVID-19 2 (INCAPS COVID 2), collecting data from 669 facilities in 107 countries, including 93 facilities in 34 U.S. states, to determine the impact of the pandemic on diagnostic cardiovascular procedure volumes. Participants reported volumes for each diagnostic imaging modality used at their facility for March 2019 (baseline), April 2020, and April 2021. This secondary analysis of INCAPS COVID 2 evaluated differences in changes in procedure volume between U.S. and non-U.S. facilities and among U.S. regions. Factors associated with return to prepandemic volumes in the United States were also analyzed in a multivariable regression analysis. Results: Reduction in procedure volumes in April 2020 compared with baseline was similar for U.S. and non-U.S. facilities (−66% vs −71%, P =.27). U.S. facilities reported greater return to baseline in April 2021 than did all non-U.S. facilities (4% vs −6%, P =.008), but there was no evidence of a difference when comparing U.S. facilities with non-U.S. high-income country (NUHIC) facilities (4% vs 0%, P =.18). U.S. regional differences in return to baseline were observed between the Midwest (11%), Northeast (9%), South (1%), and West (−7%, P =.03), but no studied factors were significant predictors of 2021 change from prepandemic baseline. Conclusion: The reductions in cardiac testing during the early pandemic have recovered within a year to prepandemic baselines in the United States and NUHICs, while procedure volumes remain depressed in lower-income countries.
KW - Angiography
KW - Cardiac
KW - Cardiac Testing
KW - Cardiovascular Disease
KW - Cardiovascular Imaging
KW - COVID-19
KW - CT
KW - CT Angiography
KW - Diagnostic Cardiovascular Procedure
KW - Echocardiography
KW - Epidemiology
KW - MR Imaging
KW - Radionuclide Studies
KW - SPECT
KW - SPECT/CT
UR - http://www.scopus.com/inward/record.url?scp=85176464884&partnerID=8YFLogxK
UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613928/
UR - https://www.research.ed.ac.uk/en/publications/cardiovascular-testing-in-the-united-states-during-the-covid-19-p-2
U2 - 10.1148/ryct.220288
DO - 10.1148/ryct.220288
M3 - Article
AN - SCOPUS:85176464884
SN - 2638-6135
VL - 5
JO - Radiology: Cardiothoracic Imaging
JF - Radiology: Cardiothoracic Imaging
IS - 5
M1 - e220288
ER -
